Novel curcumin derivatives loaded chitosan nanoparticles as therapeutic agents for alzheimer’s disease: an in-silico evaluation

Simple item page
dc.contributor.authorFernando, A. K. M
dc.contributor.authorDahanayake, J. N
dc.date.accessioned2025-09-23T04:23:16Z
dc.date.available2025-09-23T04:23:16Z
dc.date.issued2025-05
dc.descriptionPage 79 Abstract No: 2025_341
dc.description.abstractAlzheimer’s disease is an irreversible neurodegenerative disorder defined by signs and symptoms that include β-amyloid plaques, tau neurofibrillary tangles, and synaptic dysfunction.
dc.identifier.urihttps://dr.ichemc.ac.lk/handle/123456789/464
dc.language.isoen
dc.publisherInstitute of Chemistry Ceylon
dc.relation.ispartofseries42; 2
dc.subjectAcetylcholinesterase
dc.subjectAlzheimer’s disease
dc.subjectchitosan nanoparticles
dc.subjectcurcumin derivatives
dc.subjectmolecular docking
dc.titleNovel curcumin derivatives loaded chitosan nanoparticles as therapeutic agents for alzheimer’s disease: an in-silico evaluation
dc.typeArticle

Files

Original bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
Novel curcumin derivatives loaded chitosan nanoparticles as therapeutic agents for alzheimer’s disease: an in-silico evaluation
Size:
448.57 KB
Format:
Unknown data format
Download

License bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed to upon submission
Description:
Download

Collections

Abstract